Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4096 AL 4110

Optimal mesenchymal stem cell delivery routes to enhance neurogenesis for the treatment of Alzheimer's disease: optimal MSCs delivery routes for the treatment of AD

Park SE, Lee NK, Na DL, Chang JW.

Histol Histopathol. 2018 Jun;33(6):533-541. doi: 10.14670/HH-11-950. Epub 2017 Nov 29.

Editorial: Multi-target Drug Discovery - Part II

Chen JN.

Curr Top Med Chem. 2017 Nov 20;17(28):3081-3083. doi: 10.2174/156802661728171120143727.

Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease

Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR.

Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28.

The past, present, and future of disease-modifying therapies for Alzheimer's disease

Suzuki K, Iwata A, Iwatsubo T.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):757-771. doi: 10.2183/pjab.93.048.

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki-Baase EG.

Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9.

Suvorexant for the treatment of insomnia in patients with Alzheimer's disease

Hamuro A, Honda M, Wakaura Y.

Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.

Rho GTPases as therapeutic targets in Alzheimer's disease

Aguilar BJ, Zhu Y, Lu Q.

Alzheimers Res Ther. 2017 Dec 15;9(1):97. doi: 10.1186/s13195-017-0320-4.

Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease

Sahoo AK, Dandapat J, Dash UC, Kanhar S.

J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14.

Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats

Dhull DK, Kumar A.

Inflammopharmacology. 2018 Aug;26(4):925-938. doi: 10.1007/s10787-017-0431-3. Epub 2017 Dec 16.

Cinnamon, a promising prospect towards Alzheimer's disease

Momtaz S, Hassani S, Khan F, Ziaee M, Abdollahi M.

Pharmacol Res. 2018 Apr;130:241-258. doi: 10.1016/j.phrs.2017.12.011. Epub 2017 Dec 16.

Targeting Neuroinflammation to Treat Alzheimer's Disease

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, Hoeijmakers L, Hoffmann A, Iaccarino L, Jahnert S, Kuhbandner K, Landreth G, Lonnemann N, Löschmann PA, McManus RM, Paulus A, Reemst K, Sanchez-Caro JM, Tiberi A, Van der Perren A, Vautheny A, Venegas C, Webers A, Weydt P, Wijasa TS, Xiang X, Yang Y.

CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3.

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders

Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, Heales SJR, Walker MC, Williams RSB.

Lancet Neurol. 2018 Jan;17(1):84-93. doi: 10.1016/S1474-4422(17)30408-8. Epub 2017 Dec 16.

Biochemical Properties and Neuroprotective Effects of Compounds in Various Species of Berries

Kelly E, Vyas P, Weber JT.

Molecules. 2017 Dec 22;23(1):26. doi: 10.3390/molecules23010026.

Nasal steroids as a possible treatment for Alzheimer's disease

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152.

Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease

Kumar K, Kumar A, Keegan RM, Deshmukh R.

Biomed Pharmacother. 2018 Feb;98:297-307. doi: 10.1016/j.biopha.2017.12.053. Epub 2017 Dec 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias